Vista Current Coverage

All Topics Articles

Soligenix (SNGX) & SciClone (SCLN) Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis

Recently, Soligenix, Inc. (SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, and SciClone Pharmaceuticals, Inc. (SCLN), a US-based China-focused specialty pharmaceutical company, announced today that the companies have entered into an...